Skip to main content
SpringerLink
Log in

Pharmacoeconomics of Chronic Nonmalignant Pain

  • Review Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

Pain is one of the most common reasons for patients to seek medical care. In most settings, the model of acute pain treatment, with its emphasis on pharmacological therapy, is used for acute and chronic pain alike. Persistent chronic pain, however, often leads to complex social and psychological maladaptations, as well as substantial direct and indirect costs. Thus, the proper treatment of chronic pain usually involves pharmacological, behavioural and psychological interventions.

Pain is a subjective sensation, but persistent chronic pain often results in long term neurophysiological and psychological changes that might be more appropriately considered disease manifestations. Unfortunately, the subjectivity of pain has meant that the assessment of the epidemiology, pharmacotherapy and economic costs of chronic pain has been difficult. As a result. many of the techniques for chronic pain management are unfamiliar to practising physicians. Even those healthcare professionals who are familiar with the special techniques for the management of chronic pain may be unable to identify the subpopulations for which they might be most effective.

The clinician must evaluate patients for the appropriateness of a number of alternative drug delivery methods, novel analgesic agents, neuromodulatory techniques and multidisciplinary behavioural and psychological treatment programmes. The most effective treatment will often involve a combination of these techniques, as determined by the unique features of the patient’s pain condition as well as individual patient characteristics. The costs and outcomes of various treatment strategies vary considerably and there is a need for comparative studies.

Increasing emphasis on diagnosis and treatment in the primary care setting will place more importance on knowing the relative efficacies and appropriate use of a widening array of choices for chronic pain treatment. The management of chronic pain is remarkably complex and resource-intensive, and there is clearly a need for more intensive phannacoeconomic studies, especially those comparing the many alternative strategies for management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Latham J, Davis BD. The socioeconomic impact of chronic pain. Disab Rehab 1994; 16 (1): 39–44

    Article  CAS  Google Scholar 

  2. Schug SA, Large RG. Economic considerations in pain management. Pharmacoeconomics 1993; 3 (4): 260–7

    Article  PubMed  CAS  Google Scholar 

  3. Crook J, Rideout E, Browne G. The prevalence of pain complaints in a general population. Pain 1984; 18: 299–314

    Article  PubMed  CAS  Google Scholar 

  4. Brattberg G, Thorslund M, Wikman A. The prevalence of pain in a general population: the results of a postal survey in acounty of Sweden. Pain 1989; 37: 215–22

    Article  PubMed  CAS  Google Scholar 

  5. Bonica JJ. The management of pain. 2nd ed. Philadelphia: Lea and Febiger, 1990: 159–97

    Google Scholar 

  6. Von Korff M, Wagner EH, Dworkin SF, et al. Chronic pain and use of ambulatory health care. Psychosom Med 1991; 53: 61–79

    Google Scholar 

  7. Hitchcock LS, Ferrell BR, Mc Caffery M. The experience of chronic non—malignant pain. J Pain Symptom Manage 1994; 9: 312–8

    Article  PubMed  CAS  Google Scholar 

  8. James FR, Large RG. Chronic pain and the use of health services. N Z Med J 1992; 105: 196–8

    PubMed  CAS  Google Scholar 

  9. Grichnik KP, Ferrante MF. The difference between acute and chronic pain. Mt Sinai J Med 1991; 58: 217–20

    PubMed  CAS  Google Scholar 

  10. Koch H. The management of chronic pain in office-based ambulatory care: National Ambulatory Medical Care Survey. Advance Data for Vital and Health Statistics, no. 123, DHHSpublication no. (PHS) 86–1250. Hyattsville (MD): Public Health Service, 1986

    Google Scholar 

  11. World Health Organization. Cancer pain relief and palliative care: report of a WHO expert committee. Technical reportseries 804. Geneva: World Health Organization, 1990

    Google Scholar 

  12. Bradley JD, Brandt KD, Katz BP, et al. Comparison of an inflammatory dose of ibuprofen, an a analgesic dose of ibuprofen, and acetaminophen in the treatment of patients withosteoarthritis of the knee. N Engl J Med 1991; 325: 87–91

    Article  PubMed  CAS  Google Scholar 

  13. Williams HJ, Ward JR, Egger MJ, et al. Comparison of naproxen and acetaminophen in a two—year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993; 36: 1196–206

    Article  PubMed  CAS  Google Scholar 

  14. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Arthritis Rheum 1995; 38: 1535–40

    Article  PubMed  CAS  Google Scholar 

  15. Management of cancer pain: clinical practice guideline, no. 9. US Department of Health and Human Services, 1994

    Google Scholar 

  16. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. JAMA 1995; 274 (23): 1870–3

    Article  PubMed  CAS  Google Scholar 

  17. Wynne HA, Campbell M. Pharmacoeconomics of nonsteroidal anti—inflammatory drugs (NSAIDs). Pharmacoeconomics 1993; 3: 107–23

    Article  PubMed  CAS  Google Scholar 

  18. de Pouvourville G. Preventing NSAID—induced gastrointestinal toxicity. Pharmacoeconomics 1995; 7: 99–110

    Article  PubMed  Google Scholar 

  19. Smalley WE, Griffin MR, Fought RL, et al. Effect of a priorauthorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients. N Engl J Med 1995; 332: 1612–7

    Article  PubMed  CAS  Google Scholar 

  20. Kohldney AL, Klipper A. Final report on the cost of treating arthritic disease: comparison between salicylates and nonsalicylatenonsteroidal anti—inflammatory drugs. Semin Arthritis Rheum 1985: 14 (1 Suppl.): 20S–4S

    Google Scholar 

  21. Greene JM, Winickoff RN. Cost—conscious prescribing on nonsteroidal anti—inflammatory drugs for adults with arthritis. Arch Intern Med 1992; 152: 1995–2002

    Article  PubMed  CAS  Google Scholar 

  22. de Pouvourville G. The economic consequences of NSAIDinduced gastropathy: the French context. Scand J Rheumatol 1992: 96 Suppl.: 49–53

    Article  Google Scholar 

  23. Hillman AL, Bloom BS. Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidalanti—inflammatory drugs. Arch Intern Med 1989: 149: 2061–5

    Article  PubMed  CAS  Google Scholar 

  24. Jonsson B, Haglund U. Cost—effectiveness of misoprostol in Sweden. Int J Technol Assess Health Care 1992; 8: 234–44

    Article  PubMed  CAS  Google Scholar 

  25. Carrin GJ, Torrs KE. Economic evaluation of prophylactic treatment with misoprostol in osteoarthritic patients treated with NSAlDs: the case in Belgium. Rev Epidemiol Med Soc Sante Publique 1990; 38: 187–99

    CAS  Google Scholar 

  26. Barradell LB, Whittington R, Benfield P. Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenaldamage induced by nonsteroidal anti—inflammatorydrugs. Pharmacoeconomics 1993: 3: 140–70

    Article  PubMed  CAS  Google Scholar 

  27. Carson JL, Strom BL, Morse ML, et al. The relative gastrointestinal toxicity of the nonsteroidal anti—inflammatorydrugs. Arch Intern Med 1987: 147: 1054–9

    Article  PubMed  CAS  Google Scholar 

  28. Grahame R. Transdermal non—steroidal anti—inflammatory agents. Br J Clin Pract 1995; 49: 33–5

    PubMed  CAS  Google Scholar 

  29. White B, Sanders SH. The influence of patients’ pain intensity ratings of antecedent reinforcement of pain talk or well talk. J Behav Ther Exp Psychiatry 1986: 17: 155–9

    Article  PubMed  CAS  Google Scholar 

  30. Portenoy RK. Chronic opioid therapy in non—malignant pain. J Pain Symptom Manage 1990 Feb: Suppl. 1: 46S–62S

    Google Scholar 

  31. Portenoy RK, Foley KM. The chronic use of opioid analgesics in nonmalignant pain. Pain 1986: 25: 171–86

    Article  PubMed  CAS  Google Scholar 

  32. France RD, Urban BJ, Keefe FJ. Long—term use of narcotic analgesics in chronic pain. Soc Sci Med 1984; 19: 1379–82

    Article  PubMed  CAS  Google Scholar 

  33. Taub A. Opioid analgesia in the treatment of chronic intractable pain of non—neoplastic origin. In: Kitahata LM, Collins D, editors. Narcotic analgesics in anesthesiology. Baltimore: Williams and Wilkins, 1982: 199–208

    Google Scholar 

  34. Brena SF, Sanders SH. Opioids in non—malignant pain: questions in search of answers. Clin J Pain 1991; 7: 342–5

    Article  PubMed  CAS  Google Scholar 

  35. Amer S, Myerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988: 33: 11–23

    Article  Google Scholar 

  36. Mc Quay HJ, Jadad AR, Carroll D, et al. Opioid sensitivity of chronic pain: a patient-controlled analgesia method. Anaesthesia 1992; 47: 757–67

    Article  Google Scholar 

  37. Fainsinger R, Schoeller T, Bruera E. Methadone in the management of cancer pain: a review. Pain 1993; 52: 137–45

    Article  PubMed  CAS  Google Scholar 

  38. Boreau F, Saudubray F, D’ Amoux C, et al. A comparative study of controlled—release morphine (CRM) suspension and CRM tablets in chronic cancer pain. J Pain Symptom Manage 1992: 7: 393–99

    Article  Google Scholar 

  39. Chary S, Goughnour BR, Moulin DE, et al. The dose—response relationship of controlled—release codeine (Codeine Contin) in chronic cancer pain. J Pain Symptom Manage 1994; 9: 363–71

    Article  PubMed  CAS  Google Scholar 

  40. Hays H, Hagen N, Thirlwell M, et al. Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain. Cancer 1994: 74: 1808–16

    Article  PubMed  CAS  Google Scholar 

  41. Ferrell B, Wisdom C, Wenzl C, et al. Effects of controlledrelease morphine on quality—of—life for cancer pain. Oncol Nurs Forum 1989: 16: 521–6

    PubMed  CAS  Google Scholar 

  42. Bloor K, Leese B, Maynard A. The costs of managing severe cancer pain and potential savings from transdermal administration. Eur J Cancer 1994; 30A: 463–8

    Article  PubMed  CAS  Google Scholar 

  43. Byas-Smith MG, Max MB, Muir J, et al. Transdermal c10nidine compared to placebo in painful diabetic neuropathy using a two—stage ‘enriched enrollment’ design. Pain 1995: 60: 267–74

    Article  PubMed  CAS  Google Scholar 

  44. Egbunike IG, Chaffee B. Antidepressants in the management of chronic pain states. Pharmacotherapy 1990: 10: 262–70

    PubMed  CAS  Google Scholar 

  45. Zeigler D, Lynch SA, Muir J, et al. Transdermal clonidine versus placebo in painful diabetic neuropathy. Pain 1992; 48: 403–8

    Article  PubMed  CAS  Google Scholar 

  46. Davis KD, Treede RD, Raja SN, et al. Topical application of c10nidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain 1991; 47: 309–17

    Article  PubMed  CAS  Google Scholar 

  47. Carroll D, Jadad A, King V, et al. Single—dose, randomized, double—blind, double—dummy cross—over comparison of extradural and i.v. clonidine in chronic pain. Br J Anaesth 1993; 71: 665–9

    Article  PubMed  CAS  Google Scholar 

  48. Boas RA, Covino BG, Shahnarian A. Analgesic responses to i. v. lignocaine. Br J Anaesth 1982; 54: 501–5

    Article  PubMed  CAS  Google Scholar 

  49. Edwards WT. Intravenous lidocaine in the management of various chronic pain states: a review of 211 cases. Reg Anaesth 1985; 10: 1–6

    Google Scholar 

  50. Brose WG, Cousins MI. Subcutaneous lidocaine for treatment of neuropathic cancer pain. Pain 1991; 45: 145–8

    Article  PubMed  CAS  Google Scholar 

  51. Kastrup J, Angelo H, Petersen P, et al. Treatment of chronic painful diabetic neuropathy with intravenous lidocaine infusion. Br Med J Clin Res Ed 1986 Jan 18; 292: 173

    Google Scholar 

  52. Dejgard A, Petersen P, Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1988 Jan; 1 (8575-6): 9–11

    Google Scholar 

  53. Chabal C, Jacobson L, Mariano A, et al. The use of oral mexiIetine for the treatment of pain after peripheral nerve injury. Anesthesiology 1992; 76: 513–7

    Article  PubMed  CAS  Google Scholar 

  54. Ellenberg M. Treatment of diabetic neuropathy with diphenylhydantoin. NY State J Med 1968; 68: 2653–5

    CAS  Google Scholar 

  55. Tanelian DL, Brose WG. Neuropathic pain can be relieved by drugs that are use—dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology 1991; 74: 949–51

    Article  PubMed  CAS  Google Scholar 

  56. Mellick GA, Mellicy LB, Mellick LB. Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Manage 1995: 10: 265–6

    Article  PubMed  CAS  Google Scholar 

  57. Backonja M, Arndt G, Gombar KA, et al. Response of chronic neuropathic syndrome to ketamine: a preliminary study. Pain 1994; 56: 51–7

    Article  PubMed  CAS  Google Scholar 

  58. Eide K, Stubhaug A, Oye I, et al. Continuous subcutaneous administration of N—methyl—D—aspartic acid (NMDA) receptorantagonist ketamine in the treatment of post herpetic neuralgia. Pain 1995: 61: 221–8

    Article  PubMed  CAS  Google Scholar 

  59. Price DD, Mao J, Frenk H, et al. The N—methyl—D—aspartate receptor antagonist dextromethorphan selectively reducestemporal summation of second pain in man. Pain 1994: 59: 165–74

    Article  PubMed  CAS  Google Scholar 

  60. Max MB. Treatment of post—herpetic neuralgia: antidepressants. Ann Neurol 1994; 35 Suppl.: S50–3

    Article  Google Scholar 

  61. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326 (19): 1250–60

    Article  PubMed  CAS  Google Scholar 

  62. Catterall WA. Common modes of drug action on Na+ channels: local anesthetics, antiarrhythmics and anticonvulsants. TIPS 1987; 8: 57–64

    CAS  Google Scholar 

  63. Mc Quay HJ, Carroll D, Jadad AR, et al. Dextromethorphan for the treatment of neuropathic pain: a double—blind randomised controlled crossover trial with integral n—of—1 design. Pain 1994; 59: 127–33

    Article  Google Scholar 

  64. Hassenbusch SJ, Stanton-Hicks MD, Soukup J, et al. Sufentanil citrate and morphinelbupivacaine as alternative agents inchronic epidural infusions for intractable non—cancer pain. Neurosurgery 1991; 29: 76–81

    Article  PubMed  CAS  Google Scholar 

  65. Follett KA, Hitchon PW, Piper J, et al. Response of intractable pain to continuous intrathecal morphine: a retrospectivestudy. Pain 1992; 49: 21–5

    Article  PubMed  CAS  Google Scholar 

  66. Auld AW, Murdoch DM, O’Laughlin KA. Intraspinal narcotic analgesia: pain management in the failed laminectomy syndrome. Spine 1987; 12: 953–4

    Article  PubMed  CAS  Google Scholar 

  67. Penn RD, Paice JA. Chronic intrathecal morphine for intractable pain. J Neurosurg 1987; 67: 182–6

    Article  PubMed  CAS  Google Scholar 

  68. Rauck RL, Eisenach JC, Jackson K, et al. Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology 1993; 79: 1163–9

    Article  PubMed  CAS  Google Scholar 

  69. Coombs DW, Saunders RL, Gaylor MS, et al. Relief of continuous chronic pain by intraspinal narcotics infusion via an implantedreservoir. JAMA 1983; 250: 2336–9

    Article  PubMed  CAS  Google Scholar 

  70. Nance P, Schryvers O, Schmidt B, et al. Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci 1995; 22: 22–9

    PubMed  CAS  Google Scholar 

  71. Kwan JW. Use of infusion devices for epidural or intrathecal administration of spinal opioids. Am J Hosp Pharrn 1990; 47 Suppl. 1: S18–23

    Google Scholar 

  72. Bedder MD, Burchiel K, Larson A. Cost analysis of two implantable narcotic delivery systems. J Pain Symptom Manage 1991; 6: 368–73

    Article  PubMed  CAS  Google Scholar 

  73. Bel S, Bauer BL. Dorsal column stimulation (DCS): cost to benefit analysis. Acta Neurochir 1991; 52: 121–3

    Article  CAS  Google Scholar 

  74. Cousins MJ, Bridenbaugh PO. Neural blockade in clinical anesthesia and management of pain. 2nd edition. Philadelphia: JB Lippincott Co., 1988: 1085–108

    Google Scholar 

  75. North RB, Ewend MG, Lawton MT, et al. Failed back surgery syndrome: 5−year follow—up after spinal cord stimulator implantation. Neurosurgery 1991; 28: 692–9

    Article  PubMed  CAS  Google Scholar 

  76. Le Doux MS, Langford KH. Spinal cord stimulation of the failed back syndrome. Spine 1993; 18: 191–4

    Article  Google Scholar 

  77. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: a meta—analytic review. Pain 1992; 49: 221–30

    Article  PubMed  CAS  Google Scholar 

  78. Carosella AM, Lackner JM, Feuerstein M. Factors associated with early discharge from a multidisciplinary work rehabilitation program for chronic low back pain. Pain 1994; 57: 69–76

    Article  PubMed  CAS  Google Scholar 

  79. Tota-Faucette ME, Gil KM, Williams DA, et al. Predictors of response to pain management treatment: the role of family environment and changes in cognitive processes. Clin J Pain 1993; 9: 115–23

    Article  PubMed  CAS  Google Scholar 

  80. Jensen MP, Turner JA, Romano JM. Correlates of improvement in multidisciplinary treatment of chronic pain. J Consult Clin Psychol 1994; 62: 172–9

    Article  PubMed  CAS  Google Scholar 

  81. Lipchik GL, Milles K, Covington EC. The effects of multidisciplinary pain management treatment on locus of control and pain beliefs in chronic non—terminal pain. Clin J Pain 1991 Mar; 9: 49–57

    Google Scholar 

  82. Deyo RA, Diehl AK. Psychosocial predictors of disability in patients with low back pain. J Rheumatol 1988; 15: 1557–64

    PubMed  CAS  Google Scholar 

  83. King SA, Snow BR. Factors for predicting premature termination from a multidisciplinary inpatient chronic pain program. Pain 1989; 39: 281–7

    Article  PubMed  CAS  Google Scholar 

  84. Turk DC, Rudy TE, Sorkin BA, et al. Neglected factors in chronic pain treatment outcome studies: determination of success. Pain 1993; 3: 7–25

    Google Scholar 

  85. Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self—management in patients withchronic arthritis has sustained health benefits while reducinghealth care costs. Arthritis Rheum 1993; 36: 439–46

    Article  PubMed  CAS  Google Scholar 

  86. Gallagher R, Rauh V, Haugh L, et al. Determinants of return to work among low back pain patients. Pain 1989; 39: 55–67

    Article  PubMed  CAS  Google Scholar 

  87. Deardorff WW, Rubin HS, Scott DW, et al. Comprehensive multidisciplinary treatment of chronic pain: a follow—up study of treated and non—treated groups. Pain 1991; 45: 35–43

    Article  PubMed  CAS  Google Scholar 

  88. Linton SJ, Bradley LA. An 18−month follow—up of a secondary prevention program for back pain: help and hindrance factorsrelated to outcome maintenance. Clin J Pain 1992; 8: 227–36

    Article  PubMed  CAS  Google Scholar 

  89. Caudill M, Schnable R, Zuttermeister P, et al. Decreased clinic use by chronic pain patients: response to behavioral medicineintervention. Clin J Pain 1991; 7: 305–10

    Article  PubMed  CAS  Google Scholar 

  90. Luscombe FE, Wallace L, Williams J, et al. A district general hospital pain management programme — first year experiencesand outcomes. Anesthesia 1995; 50: 114–7

    Article  CAS  Google Scholar 

  91. Gutkin AJ, Holborn SW, Walker JR, et al. Cost—effectiveness of home relaxation training for tension headaches. J Behav Ther Exp Psychiatry 1994; 25: 69–74

    Article  PubMed  CAS  Google Scholar 

  92. Frymoyer JW, Cats-Baril WL. An overview of the incidence and costs of low back pain. Orthop Clin North Am 1991; 22: 263–71

    PubMed  CAS  Google Scholar 

  93. de Girolamo G. Epidemiology and social costs of low back pain and fibromyalgia. Clin J Pain 1991; 7 Suppl. 1: S1–7

    Google Scholar 

  94. Taylor H, Curran N. The Nuprin pain report. New York: Louis Harris and Associates, 1985

    Google Scholar 

  95. Borenstein D. Epidemiology, etiology, diagnostic evaluation, and treatment of low back pain. Curr Opin Rheumatol 1995; 7: 141–6

    Article  PubMed  CAS  Google Scholar 

  96. Webster BS, Snook SH. The cost of 1989 workers’ compensation low back pain claims. Spine 1994; 19: 1111–5, discussion 1116

    Article  PubMed  CAS  Google Scholar 

  97. Liu AC, Byrne E. Cost of care for ambulatory patients with low back pain. J Fam Pract 1995; 40: 449–55

    PubMed  CAS  Google Scholar 

  98. Deyo RA, Rainville J, Kent DI. What can the history and physical examination tell us about low back pain? JAMA 1992; 268: 760–5

    Article  PubMed  CAS  Google Scholar 

  99. Carey TS, Evans A, Hadler N, et al. Care—seeking among individuals with chronic low back pain. Spine 1995; 20: 312–7

    Article  PubMed  CAS  Google Scholar 

  100. Taylor VM, Deyo RA, Cherkin DC, et al. Low back pain hospitalization: recent United States trends and regional variations. Spine 1994; 19: 1207–13

    Article  PubMed  CAS  Google Scholar 

  101. Elam KC, Cherkin DC, Deyo RA. How emergency physicians approach low back pain: choosing costly options. J Emerg Med 1995 Mar—Apr; 13: 143–50

    Google Scholar 

  102. Frymoyer JW, Cats-Baril W. Predictors of low back pain disability. Clin Orthop 1987; 221: 89–98

    PubMed  Google Scholar 

  103. Andersson GBJ, Svensson HO, Oden A. The intensity of work recovery in low back pain. Spine 1983; 8: 880

    Article  PubMed  CAS  Google Scholar 

  104. Biering-Sorenson F. Low back trouble in a general population of 30—,40—,50—, and 6O−year old men and women: study design, representativeness and basic results. Dan Med Bull 1982; 29: 239

    Google Scholar 

  105. Von Korff M, Barlow W, Cherkin D, et al. Effects of practice style in managing back pain. Ann Intern Med 1994: 121: 187–95

    Google Scholar 

  106. AHCPR Guidelines. Acute low back problems in adults: assessment and treatment. No. 95-0643. 1994: 1–25

    Google Scholar 

  107. Assendelft WJ, Bouter LM. Does the goose really lay golden eggs? A methodological review of workmen’s compensationstudies. J Manipulative Physiol Ther 1993: 16: 161–8

    PubMed  CAS  Google Scholar 

  108. Bergemann BW, Cichoke AJ. Cost—effectiveness of medical vs. chiropractic treatment of low—back injuries. J Manipulative Physiol Ther 1980: 3: 143–7

    Google Scholar 

  109. Dean H, Schmidt R. A comparison of the cost of chiropractors versus alternative medical practitioners. Richmond: Virginia Chiropractic Association, 1992

    Google Scholar 

  110. Jarvis KB, Phillips RB, Morris EK. Cost per case comparison of back injury claims of chiropractic versus medical managementfor conditions with identical diagnostic codes. J Occup Med 1991: 33: 847–52

    Article  PubMed  CAS  Google Scholar 

  111. Johnson MR, Schultz MK, Ferguson AC. A comparison of chiropractic, medical and osteopathic care for work—relatedsprains and strains. J Manipulative Physiol Ther 1989: 12: 335–44

    PubMed  CAS  Google Scholar 

  112. Nyiendo J, Lamm L. Disabling low back Oregon workers’ compensation claims: part I. Methodology and clinical categorization of chiropractic and medical cases. J Manipulative Physiol Ther 1991: 14: 177–84

    PubMed  CAS  Google Scholar 

  113. Nyiendo J. Disabling low back Oregon workers’ compensation claims: part II. Time loss. J Manipulative Physiol Ther 1991: 14: 231–9

    PubMed  CAS  Google Scholar 

  114. Nyiendo J. Disabling low back Oregon workers’ compensation claims: part III. Diagnostic and treatment procedures and associatedcosts. J Manipulative Physiol Ther 1991: 14: 287–97

    PubMed  CAS  Google Scholar 

  115. Stano M. A comparison of health care costs for chiropractic and medical patients. J Manipulative Physiol Ther 1993: 16: 291–9

    PubMed  CAS  Google Scholar 

  116. Wolk S. An analysis of Florida workers’ compensation medical claims for back—related injuries. American Chiropractic Association Journal 1988: 27: 50–9

    Google Scholar 

  117. Shekelle PG, Markovich M, Louie R. Comparing the costs between provider types of episodes of back pain care. Spine 1995: 20: 221–7

    Article  PubMed  CAS  Google Scholar 

  118. Carey TS, Garrett J, Jackman A, et al. The outcomes and costs of care for acute low back pain among patients seen by primarycare practitioners, chiropractors, and orthopedic surgeons: the North Carolina Back Pain Project. N Engl J Med 1995: 333: 913–7

    Article  PubMed  CAS  Google Scholar 

  119. Hourigan PG, Weatherley CR. Initial assessment and follow—up by a physiotherapist of patients with back pain referred to aspinal clinic. J R Soc Med 1994: 87: 213–4

    PubMed  CAS  Google Scholar 

  120. Schroth WS, Schectman JM, Elinsky EG, et al. Utilization of medical services for the treatment of acute low back pain: conformance with clinical guidelines. J Gen Intern Med 1992: 7: 486–91

    Article  PubMed  CAS  Google Scholar 

  121. Jensen MC, Brant Zawadzki MN, Obuchowski N, et al. Magnetic resonance imaging of the lumbar spine in people withoutback pain. N Engl J Med 1994: 331: 69–73

    Article  PubMed  CAS  Google Scholar 

  122. Boden SD, Davis DO, Dina TS, et al. Abnormal magnetic resonance scans of the lumbar spine in asymptomatic subjects: a prospective investigation. J Bone Joint Surg Am 1990: 72: 403–8

    PubMed  CAS  Google Scholar 

  123. Jette AM, Smith K, Haley SM, et al. Physical therapy episodes of care for patients with low back pain. Phys Ther 1994: 74: 101–10

    PubMed  CAS  Google Scholar 

  124. Volinn E, Turczyn KM, Loeser JD. Patterns in low back pain hospitalizations: implications for the treatment of low back pain in an era of health care reform. Clin J Pain 1994: 10: 64–70

    Article  PubMed  CAS  Google Scholar 

  125. Cherkin DC, Deyo RA, Loeser JD, et al. An international comparison of back surgery rates. Spine 1994: 19: 1201–6

    PubMed  CAS  Google Scholar 

  126. Loeser JC, Bigos SJ, Fordyce WE, et al. Low back pain. In: Bonica JJ, editor. The management of pain. 2nd ed. Pennsylvania: Lea and Febiger, 1990: 1448–83

    Google Scholar 

  127. North RB, Campbell JN, Names CS, et al. Failed back surgery syndrome: five year follow—up in 102 patients undergoing repeated operation. Neurosurgery 1991; 28: 685–91

    Article  PubMed  CAS  Google Scholar 

  128. Walker S, Cousins MJ. Failed back surgery syndrome. Aust Fam Physician 1994: 23: 2308–14

    PubMed  CAS  Google Scholar 

  129. Sandstrom J, Esbjornsson E. Return to work after rehabilitation: the significance of the patient’s own prediction. Scand J Rehabil Med 1986: 18: 29–33

    PubMed  CAS  Google Scholar 

  130. Svensson HO, Andersson GBJ. Low back pain in 40–47−year old men: 1. Frequency of occurrence and impact on medical services. Scand J Rehabil Med 1982: 14: 47

    PubMed  CAS  Google Scholar 

  131. Vallfors B. Acute, subacute, and chronic low back pain: clinical symptoms, absenteeism, and working environment. Scand J Rehabil Med 1985: Suppl. 1: 1–98

    Google Scholar 

  132. Feuerstein M, Suit S, Houle M. Environmental stressors and chronic low back pain: life events, family and work environment. Pain 1985: 22: 295–307

    Article  PubMed  CAS  Google Scholar 

  133. Bigos SJ, Battie MC, Spengler DM. A prospective study of work perceptions and psychosocial factors affecting the reportof back injury. Spine 1991: 16: 1–6

    Article  PubMed  CAS  Google Scholar 

  134. Feuerstein M, Thebarge RW. Perceptions of disability and occupational stress as discriminators of work disability in patients with chronic pain. J Occup Rehab 1991: 1: 185–95

    Article  Google Scholar 

  135. Waddell G, Main CJ. Assessment of severity in low back disorders. Spine 1984; 9: 204–8

    Article  PubMed  CAS  Google Scholar 

  136. Milhous RL, Haugh LD, Frymoyer JW, et al. Determinants of vocational disability in patients with low back pain. Arch Phys Med Rehabil 1989: 70: 589–93

    PubMed  CAS  Google Scholar 

  137. Sanderson PL. Compensation, work status, and disability in 10” back pain patients. Spine 1995: 20: 554–6

    Article  PubMed  CAS  Google Scholar 

  138. Greenough CG, Fraser RD. The effects of compensation on recovery from low back pain. Spine 1989; 14: 947–55

    Article  PubMed  CAS  Google Scholar 

  139. Sander RA, Meyers JE. The relationship of disability to compensation status in railway workers. Spine 1986: 11: 141–3

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Technology Assessment Group, 490 Second Street, Suite 201, San Francisco, California, 94107, USA

    Martin J. Zagari & Peter D. Mazonson

  2. Department of Anaesthesia, Division of Pain Management, Stanford, California, USA

    William C. Longton

Authors
  1. Martin J. Zagari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter D. Mazonson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William C. Longton
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zagari, M.J., Mazonson, P.D. & Longton, W.C. Pharmacoeconomics of Chronic Nonmalignant Pain. Pharmacoeconomics 10, 356–377 (1996). https://doi.org/10.2165/00019053-199610040-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199610040-00005

Keywords

Search

Navigation